A valuation company who wrote a textbook on the subject previously valued Elite in the billions based on company assets and potential at the time. An independent, unbiased analyst was previously the CEO of Elite and was highly bullish on its tech and pipeline, so much so that he lent the company money from his own pocket. R&D companies currently being acquired do not have anywhere near the pipeline or manufacturing capabilities that Elite does. Yes, it is a FACT that Elite is undervalued comparatively. Just because analysts do not typically follow OTC companies/stocks does not automatically mean they have no value. Thanks.